Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 211

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

Open access
Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., Beglinger, C. · 2001 · Alimentary Pharmacology & Therapeutics

Abstract

Background: Serotonin and its type‐4 (5‐hydroxytryptamine 4 ) receptor play a major role in the physiology of the gastrointestinal tract. The effect of intravenous and/or oral tegaserod, a 5‐hydroxytryptamine 4 receptor partial agonist, on gastric emptying, small bowel transit and colonic transit has not been studied in detail in humans. Aim: To assess the pharmacodynamic effects of repeated oral and intravenous administration of tegaserod on gastric emptying and small intestine and colonic transit. Methods: A randomized, placebo‐controlled, double‐blind, three‐way, crossover study of 6 mg oral and 0.6 mg intravenous tegaserod in 12 healthy male subjects was performed. Each treatment arm of the study involved 3 days of twice‐daily administration and 1 day of daily administration of the study drugs. Results: In comparison with placebo, oral and intravenous tegaserod significantly increased the gastric emptying rate ( P < 0.01), accelerated colonic filling ( P < 0.01) and shortened colonic transit at 48 h ( P < 0.05). Tegaserod shortened the small intestine transit time by 30% after oral and by 37% after intravenous administration. Conclusions: In healthy subjects, tegaserod markedly accelerated gastric emptying and small intestinal transit, and induced a small but significant acceleration of colonic transit. Tegaserod can act as a promotile agent throughout the gastrointestinal tract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2001.01103.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 211

Metadata

Authors
Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., & Beglinger, C.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2001-11-06
Volume
15
Issue
11
Pages
1745-1751
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2023618163
Cited by
211
References
1
FWCI
15.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. https://app.cochat.ai/papers/10.1046/j.1365-2036.2001.01103.x
The paper
Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., & Beglinger, C. (2001). Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2001.01103.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.